Literature DB >> 14505280

Q fever as a biological weapon.

Frank T Kagawa1, John H Wehner, Vibha Mohindra.   

Abstract

Q fever is a bacterial zoonosis caused by Coxiella burnetii, a unique intracellular coccobacillus, adapted to live within the phagolysosomes of macrophages and monocytes. It is highly infectious, with as little as one organism needed to cause clinical infection, making it an attractive organism for use in biowarfare. Despite its high infectivity, it has low virulence, and most patients undergo only asymptomatic seroconversion. Acute clinical manifestations are a nonspecific febrile illness, pneumonia, hepatitis, and neurologic abnormalities ranging from headache to meningoencephalitis. Chronic Q fever can result in endocarditis, hepatitis, or a chronic fatigue syndrome. Diagnosis usually is made by serology because culture of the highly contagious organism is potentially hazardous. Tetracyclines are the antibiotics of choice. When individualized therapy is possible, a 14- to 21-day course of doxycycline usually is used. In a mass casualty situation, a 5- to 7-day course of doxycycline is recommended, both for therapy and prophylaxis. For chronic infections such as endocarditis, 18 months of doxycycline supplemented with hydroxychloroquine is currently the best therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505280

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  6 in total

1.  Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.

Authors:  Chen Chen; Erin J van Schaik; Anthony E Gregory; Adam Vigil; Phillip L Felgner; Laura R Hendrix; Robert Faris; James E Samuel
Journal:  J Infect Dis       Date:  2019-07-19       Impact factor: 5.226

2.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

3.  Proteomic and systems biology analysis of the monocyte response to Coxiella burnetii infection.

Authors:  Matt Shipman; Kirk Lubick; David Fouchard; Rajani Gurram; Paul Grieco; Mark Jutila; Edward A Dratz
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

Review 4.  The Impact of Emerging Infectious Diseases on Chinese Blood Safety.

Authors:  Miao He; Jingxing Wang; Limin Chen; Jing Liu; Peibin Zeng
Journal:  Transfus Med Rev       Date:  2016-11-04

5.  Prophylaxis after exposure to Coxiella burnetii.

Authors:  Claire E Moodie; Herbert A Thompson; Martin I Meltzer; David L Swerdlow
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

6.  ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task force I: direct cardiovascular implications of emerging infectious diseases and biological terrorism threats.

Authors:  Larry M Baddour; Zhi-Jie Zheng; Darwin R Labarthe; Siobhán O'Connor
Journal:  J Am Coll Cardiol       Date:  2007-03-27       Impact factor: 24.094

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.